SENSEX NIFTY

Ema

Mar 23, 2017 at 17:08 | Source: Moneycontrol.com
Formation of a bullish belt hold pattern after an inverted hammer is indeed a positive sign for the bulls and traders who went long on the index need not worry and keep a trailing stop loss at 9,019 levels for all long positions.
Mar 03, 2017 at 13:59 | Source: Moneycontrol.com
The court allowed the firm to make and sell Canmab, a cancer drug of the company. Stock was under pressure so far on the back of inspection reports. The management, earlier this morning, stated the inspections were expected as its dossiers were accepted by US FDA and EMA.
Mar 03, 2017 at 11:26 | Source: CNBC-TV18
Biocon Chief Kiran Mazumdar Shaw says India is not an outsourced services country anymore, it is an innovation and knowledge partner.
Mar 02, 2017 at 13:45 | Source: CNBC-TV18
Biotech company, Biocon will see two crucial inspections later this month and in early April. Companys manufacturing sites will come up for inspections by the European medicines agency later this month and next will be an inspection by the US FDA.
Jan 30, 2017 at 13:22 | Source: Moneycontrol.com
EMA India Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on February 07 2017, to consider Un-audited Financial Results of the Company for the quarter ended December 31, 2016.
Jan 12, 2017 at 08:21 | Source: Moneycontrol.com
Bengaluru-based biopharmaceutical firm Biocon on Wednesday said US drug regulator has accepted its partners Mylans biologics license application (BLA) for the proposed biosimilar of breast cancer drug Trastuzumab through the 351(k) pathway.
Jan 02, 2017 at 18:00 | Source: PTI
Engineering major Larsen & Toubro (L&T) today said its wholly-owned subsidiary L&T Hydrocarbon Engineering-led consortium has bagged two orders from oil major Saudi Aramco.
Jan 02, 2017 at 13:25 | Source: Moneycontrol.com
L&T Hydrocarbon Engineering, subsidiary of L&T, in consortium with EMAS CHIYODA Subsea, has announced the conclusion of two awards involving EPCI contracts from Saudi Aramco.
Nov 04, 2016 at 10:55 | Source: Moneycontrol.com
EMA India Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on November 12, 2016 to consider Un-audited Financial Results of the Company for the quarter ended September 30, 2016.
Nov 04, 2016 at 09:54 | Source: PTI
Mylan and Biocon, which have co-developed insulin glargine, look forward to offering another insulin treatment option for diabetic patients, who are often facing significant expense to manage their disease, Biocon said in a regulatory filing.
Messages on Ema »

rajkandhan

New Member

34 Followers

index  

10 days EMA is 9072 below that nifty is weak

8.27 PM Mar 28th

hushaam1

Gold Member

3266 Followers

GOLD  

Gold ensuring positive momentum & leans now on the intraday bullish channel`s with major resistance at 29000, once taken out with good buying volumes for bouncing higher to resume the main bullish trend that organizes within the main bullish channel, where the price gets good support from the EMA

7.16 PM Mar 28th

impact16

New Member

1 Followers

Adani Enterpris  

It has formed an evening star pattern on daily chart. initiating a long position is very risky unless and until 107 is taken out.. it will try to test its support at 13 day EMA at 102..

11.54 AM Mar 28th

kalpataru70

Platinum Member

545 Followers

Aurobindo Pharm  

are affected due to decision by European Medicines Agency (EMA) on the CRO. Some of these products are not currently on market and, in fact, are awaiting for approval in some countries. 2. The combined sales of these products is less than USD 5 mn per annum for the Company.

10.02 PM Mar 27th

CHANAKYA 123

New Member

13 Followers

Aurobindo Pharm  

See EMA has its effect ... but I am sure tomorrow or day after once the big news is out ... you will all agree to my point ... till such time i stay calm and be a observer

6.00 PM Mar 27th

hacknse

New Member

31 Followers

Petronet LNG  

every stock has an unique ema. ema 20-50, golde ratio us ema 50-200 intersection. which one do you use? success of a buy entry is 59.12%.very weak buy signal, enter with high risk. stock is also in uptrend at present! predicted high for today is 399.7. outlook is ve since price 394.10 and 10

11.16 AM Mar 27th

amateurinve
stor

Platinum Member

3128 Followers

index  

NEGATIVE ALERT FOR AUROPHARMA: Aurobindo Pharma may face the brunt of suspension call. EMA recommends suspending 300 drugs or their applications of various firms. http://t.in.com/b7nv

1.35 PM Mar 26th

savera_patn
a

Platinum Member

41 Followers

Biocon  

Inform us the month when EMA is going to approve marketing authorisation to Pegfilgrastim/Trastuzumab biosimilars ?? Applied in July/August 2016....210 days plus 60 days .. 10-12 months time ..by July 2017 maximum ): we r in last week of March settlement... April may June have to go....timeline

10.22 AM Mar 25th

winner-firs
t

New Member

6 Followers

Sun Pharma  

Sun Pharmaceutical Industries Ltd * Says validation of regulatory filing of tildrakizumab with the european medicines agency (EMA) by Almirall. * Tildrakizumab is an investigational IL-23P19 inhibitor being evaluated for the treatment of moderate-to-severe plaque psoriasis. * Filing includes

1.54 PM Mar 24th

hacknse

New Member

31 Followers

United Brewerie  

every stock has an unique ema. ema 20-50, golde ratio us ema 50-200 intersection. which one do you use? probability of ubl move upwards is 41.1%.very weak buy signal, enter with high risk. stock is in temporary downtrend. wait for it to become uptrend for fresh enteries! predicted low for today

11.23 AM Mar 24th

Follow us on
Available On